Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

- PMLiVE

Positive trial results for Janssen’s Symtuza boosts its HIV credentials

The STR provided ‘effective’ and ‘durable’ viral suppression

- PMLiVE

Amgen hopes its latest Kyprolis trial hits the mark with regulators

A.R.R.O.W study takes aim at once-weekly dosing regimen in multiple myeloma

- PMLiVE

Aelix Therapeutics appoints Dr Thomas Hecht

He joins the Spanish biotech as chairman of the board of directors

- PMLiVE

RJW & Partners appoints new director

Cathy Beecher joins from ICON

- PMLiVE

BPR Pharma strengthens research team

Vicky Davies joins the UK-based international research agency from Bedrock Healthcare

Executive Insight strengthens UK presence with new partner

David Ewbank joins the firm from McCann Health

- PMLiVE

Redefining the real value within a good value proposition

Successful value propositions

- PMLiVE

Boosting pharma’s metabolic rate

How using more diversity at the top can speed-up change

- PMLiVE

Achieving deep understanding of healthcare customer behaviour

In part one of a series on customer insight and behaviour change, Martine Leroy reveals a behaviour framework for gathering sharp insights used to help brand managers and marketers achieve...

Blue Latitude Health

- PMLiVE

Random42 celebrates at Cannes Corporate 2017

Wins gold dolphin award for Defending LIfe: The Immune Ecosystem

- PMLiVE

Shire’s gene therapy candidate receives orphan drug status in the US

Investigational factor VIII treatment SHP654 is being developed for haemophilia

- PMLiVE

CDC backs GSK’s Shingrix over Merck & Co’s Zostavax

US advisors recommend GSK's shingle vaccine be used instead of Merck's rival product

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links